Record NNP B-NP O
date NN I-NP O
: : O O
2062-09-09 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
Medical NNP I-NP O
Student NNP I-NP O
Admit NNP I-NP O
Note NNP I-NP O
Patient NNP B-NP O
: : O O
Xavier NNP B-NP B-PATIENT
S. NNP I-NP I-PATIENT
Kaufman NNP I-NP I-PATIENT
CCH VB B-NP B-HOSPITAL
Unit NN I-NP O
Number NN I-NP O
: : O O
9141027 CD O B-MEDICALRECORD
Date NNP B-NP O
of IN B-PP O
Admission NNP B-NP O
: : O O
September NNP B-NP B-DATE
06 CD I-NP I-DATE
, , I-NP I-DATE
2062 CD O I-DATE
Attending VBG B-VP O
Physician JJ B-ADJP O
: : O O
Patrick NNP B-NP B-DOCTOR
Yeates NNS I-NP I-DOCTOR
Code NNP B-NP O
Status NNP I-NP O
: : O O
Full NNP B-NP O
Source NN B-NP O
: : O O
Patient NNP B-NP O
and CC I-NP O
chart NN I-NP O
Chief NNP B-NP O
Complaint NNP I-NP O
: : O O
Shortness NNP B-NP O
of IN B-PP O
breath NN B-NP O
History NN B-NP O
of IN B-PP O
The DT B-NP O
Present NNP I-NP O
Illness NNP I-NP O
: : O O
Mr. NNP B-NP O
Kaufman NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
53 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
man NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
Insulin-requiring NNP B-NP O
DM NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
Hepatitis NNP B-NP O
C NNP I-NP O
presents NNS I-NP O
with IN B-PP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-PP O
acute JJ B-NP O
onset NN I-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
in IN B-PP O
his PRP$ B-NP O
usual JJ I-NP O
state NN I-NP O
of IN B-PP O
health NN B-NP O
when WRB B-ADVP O
one CD B-NP O
week NN I-NP O
PTA NNP B-NP O
he PRP B-NP O
decided VBD B-VP O
to TO I-VP O
abruptly RB I-VP O
discontinue VB I-VP O
his PRP$ B-NP O
Fentanyl NNP I-NP O
patch NN I-NP O
, , O O
which WDT B-NP O
he PRP B-NP O
had VBD B-VP O
for IN B-NP O
three CD I-NP O
years NNS I-NP O
at IN B-PP O
75mg CD B-NP O
for IN B-PP O
pain NN B-NP O
associated VBN B-VP O
with IN B-PP O
peripheral JJ B-NP O
neuropathy NN I-NP O
and CC I-NP O
gastroparesis NN I-NP O
. . O O
He PRP B-NP O
recently RB B-ADVP O
decided VBD B-VP O
he PRP B-NP O
no RB B-ADVP O
longer RB I-ADVP O
wanted VBD B-VP O
to TO I-VP O
wear VB I-VP O
the DT B-NP O
patch NN I-NP O
because IN B-SBAR O
he PRP B-NP O
was VBD B-VP O
concerned VBN B-ADJP O
about IN B-PP O
personality NN B-NP O
changes NNS I-NP O
and CC O O
side NN B-NP O
effects NNS I-NP O
of IN B-PP O
the DT B-NP O
medication NN I-NP O
. . B-PP O
His PRP$ B-NP O
PCP NNP I-NP O
instructed VBD B-VP O
him PRP B-NP O
to TO B-VP O
taper VB I-VP O
the DT B-NP O
medication NN I-NP O
, , O O
switching VBG B-VP O
him PRP B-NP O
to TO B-PP O
a DT B-NP O
50 CD I-NP O
mg JJ I-NP O
patch NN I-NP O
, , O O
but CC O O
Mr. NNP B-NP O
Kaufman NNP I-NP B-PATIENT
removed VBD B-VP O
the DT B-NP O
patch NN I-NP O
without IN B-PP O
a DT B-NP O
taper NN I-NP O
. . O O
He PRP B-NP O
felt VBD B-VP O
fine JJ B-ADJP O
for IN B-PP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
but CC O O
began VBD B-VP O
to TO I-VP O
experience VB I-VP O
pain NN B-NP O
in IN B-PP O
his PRP$ B-NP O
feet NNS I-NP O
, , O O
LE JJ B-NP O
edema NN I-NP O
, , O O
insomnia NN B-NP O
and CC I-NP O
rhinorrhea NN I-NP O
. . O O
On IN B-PP O
the DT B-NP O
day NN I-NP O
of IN B-PP O
admission NN B-NP O
, , O O
he PRP B-NP O
was VBD B-VP O
watching VBG I-VP O
television NN B-NP O
when WRB B-ADVP O
he PRP B-NP O
experienced VBD B-VP O
the DT B-NP O
acute JJ I-NP O
onset NN I-NP O
of IN B-PP O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
and CC I-NP O
chest NN I-NP O
tightness NN I-NP O
. . O O
He PRP B-NP O
described VBD B-VP O
the DT B-NP O
chest NN I-NP O
tightness NN I-NP O
as IN B-PP O
like IN B-PP O
someone NN B-NP O
sitting VBG B-VP O
on IN B-PP O
his PRP$ B-NP O
R NN I-NP O
chest NN I-NP O
below IN B-PP O
his PRP$ B-NP O
shoulder NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
band-like JJ I-NP O
distribution NN I-NP O
across IN B-PP O
his PRP$ B-NP O
upper JJ I-NP O
chest NN I-NP O
, , O O
intermittent JJ B-NP O
, , I-NP O
non-radiating JJ I-NP O
and CC I-NP O
somewhat RB B-VP O
relieved VBN I-VP O
by IN B-PP O
moving VBG B-VP O
his PRP$ B-NP O
R NN I-NP O
shoulder NN I-NP O
. . O O
This DT B-NP O
pain NN I-NP O
lasted VBD B-VP O
4-5 CD B-NP O
minutes NNS I-NP O
but CC O O
his PRP$ B-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
persisted VBD B-VP O
. . O O
The DT B-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
was VBD B-VP O
worse JJR B-ADJP O
with IN B-PP O
exertion NN B-NP O
, , O O
not RB B-VP O
improved VBN I-VP O
with IN B-PP O
rest NN B-NP O
and CC O O
caused VBD B-VP O
his PRP$ B-NP O
to TO B-VP O
take VB I-VP O
rapid JJ B-NP O
shallow NN I-NP O
breaths NNS I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
began VBD B-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
non-productive JJ I-NP O
cough NN I-NP O
this DT B-NP O
same JJ I-NP O
day NN I-NP O
. . O O
This DT O O
was VBD B-VP O
the DT B-NP O
first JJ I-NP O
time NN I-NP O
he PRP B-NP O
has VBZ B-VP O
ever RB I-VP O
experienced VBN I-VP O
this DT B-NP O
chest NN I-NP O
discomfort NN I-NP O
and CC I-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
nausea NN B-NP O
, , O O
vomiting VBG B-VP O
, , O O
diaphoresis NN B-NP O
, , O O
acid NN B-NP O
reflux NN I-NP O
sensation NN I-NP O
, , O O
PND NNP B-NP O
, , O O
orthopnea NN B-NP O
, , I-NP O
fever NN I-NP O
or CC I-NP O
sick JJ I-NP O
contacts NNS I-NP O
. . O O
ED VBN B-NP O
Course NNP I-NP O
: : O O
Vitals NNS B-NP O
: : O O
T NNP B-NP O
: : O O
97.9 CD B-NP O
BP NNP I-NP O
: : O O
195/115 CD B-NP O
HR NN I-NP O
: : O O
84 CD B-NP O
RR NN I-NP O
: : O O
28 CD B-NP O
Sat NNP I-NP O
: : O O
95-96 CD B-NP O
% NN I-NP O
on IN B-PP O
RA NNP B-NP O
Interventions NNS B-NP O
: : O O
1.5-2.0L CD B-NP O
NS NNS I-NP O
Kayexcelate NNP B-NP O
45mg CD I-NP O
PO NN I-NP O
ASA NNP B-NP O
325mg CD I-NP O
Norvasc NNP B-NP O
5mg CD I-NP O
PO NN I-NP O
Nexium NNP B-NP O
40mg CD I-NP O
PO NN I-NP O
Toprol NNP B-NP O
100mg CD I-NP O
PO NN I-NP O
Lopressor NNP B-NP O
5mg CD I-NP O
IV NNP I-NP O
Morphine NNP B-NP O
sulfate NN I-NP O
1mg CD B-NP O
IV NNP I-NP O
MSO4 NNP B-NP O
1mg CD I-NP O
IV NNP I-NP O
Studies NNS B-NP O
: : O O
K+=5.6 FW B-NP O
( -LRB- I-NP O
9/06/62 JJ I-NP B-DATE
5:02AM NNS I-NP O
) -RRB- O O
EKG NN B-NP O
: : O O
see VB B-VP O
Data NNP B-NP O
section NN I-NP O
CXR NN B-NP O
: : O O
see VB B-VP O
Data NNP B-NP O
section NN I-NP O
Past NNP B-NP O
Medical/Surgical NNP I-NP O
History NNP I-NP O
: : O O
Diabetes NNP B-NP O
Mellitus NNP I-NP O
: : O O
dx JJ B-NP O
18 CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
used VBD B-VP O
Insulin NNP B-NP O
in IN B-PP O
past NN B-NP O
, , O O
has VBZ B-VP O
only RB I-VP O
used VBN I-VP O
for IN B-PP O
1-2 JJ B-NP O
weeks NNS I-NP O
in IN B-PP O
past JJ B-NP O
year NN I-NP O
, , O O
last JJ B-NP O
HgbA1c JJ I-NP O
5.4 CD I-NP O
( -LRB- I-NP O
8/17/62 NN I-NP B-DATE
) -RRB- I-NP O
, , O O
complications NNS B-NP O
include VBP B-VP O
peripheral JJ B-NP O
neuropathy NN I-NP O
, , O O
retinal JJ B-NP O
disease NN I-NP O
, , O O
gastroparesis NN B-NP O
and CC O O
numerous JJ B-NP O
LE JJ I-NP O
ulcers NNS I-NP O
Hypertension NNP B-NP O
: : O O
initially RB B-VP O
labeled VBN I-VP O
as IN B-PP O
labile NN B-NP O
hypertension NN I-NP O
, , O O
SBP NNP B-NP O
's POS B-NP O
often RB B-ADJP O
in IN B-PP O
190's-200 CD B-NP O
's POS B-NP O
, , O O
on IN O O
multiple JJ B-NP O
medical JJ I-NP O
regimens NNS I-NP O
in IN B-PP O
past NN B-NP O
Chronic NNP B-NP O
renal JJ I-NP O
failure NN I-NP O
: : O O
creatinine CD B-NP O
>1.5 CD I-NP O
starting VBG B-VP O
in IN B-PP O
9/61 CD B-NP B-DATE
Hepatitis NNP B-NP O
C NNP I-NP O
: : O O
viral JJ B-NP O
load NN I-NP O
>1,000,000 CD I-NP O
in IN B-PP O
2/22 CD B-NP B-DATE
, , O O
thought VBD B-VP O
to TO I-VP O
be VB I-VP O
acquired VBN I-VP O
through IN B-PP O
sexual JJ B-NP O
contact NN I-NP O
, , O O
denies VBZ B-VP O
IV NNP B-NP O
drug NN I-NP O
use NN I-NP O
Allergies NNP B-NP O
: : O O
Reglan- NNP B-NP O
dystonia NN I-NP O
Medications NNS B-NP O
: : O O
HCTZ NNP B-NP O
25mg CD I-NP O
PO NNP I-NP O
QD NNP I-NP O
Lisinopril NNP B-NP O
20mg CD I-NP O
PO NNP I-NP O
QD NNP I-NP O
Toprol NNP B-NP O
XL NNP I-NP O
100mg CD I-NP O
PO NNP I-NP O
QD NNP I-NP O
Norvasc NNP B-NP O
5mg CD I-NP O
PO NNP I-NP O
BID NNP I-NP O
Neurontin NNP B-NP O
600mg CD I-NP O
PO NNP I-NP O
QD NNP I-NP O
Protonix NNP B-NP O
40 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QD . O O
Insulin NN B-NP O
? . O O
( -LRB- O O
pt NN B-NP O
states NNS I-NP O
he PRP B-NP O
has VBZ B-VP O
n't RB I-VP O
taken VBN I-VP O
Insulin NNP B-NP O
in IN B-PP O
months NNS B-NP O
) -RRB- O O
Social NNP B-NP O
History NNP I-NP O
: : O O
Lives NNS B-NP O
in IN B-PP O
Altavista NNP B-NP B-CITY
, , O O
VA NNP B-NP B-STATE
with IN B-PP O
wife NN B-NP O
and CC O O
their PRP$ B-NP O
two CD I-NP O
children NNS I-NP O
, , O O
ages NNS B-NP O
24 CD I-NP B-AGE
and CC I-NP O
26 CD I-NP B-AGE
. . O O
Retired VBN B-VP O
as IN B-PP O
statistical JJ B-NP B-PROFESSION
programmer NN I-NP I-PROFESSION
at IN B-PP O
Electronic NNP B-NP B-ORGANIZATION
Data NNP I-NP I-ORGANIZATION
after IN B-PP O
DM NNP B-NP O
diagnosis NN I-NP O
18 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
. . O O
No DT B-NP O
smoking NN I-NP O
history NN I-NP O
, , O O
heavy JJ B-NP O
drinking NN I-NP O
history NN I-NP O
, , O O
stopped VBD B-VP O
10 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
remote JJ B-NP O
drug NN I-NP O
history NN I-NP O
of IN B-PP O
acid NN B-NP O
and CC I-NP O
speed NN I-NP O
use NN I-NP O
. . O O
Family NNP B-NP O
History NN I-NP O
: : O O
Father NNP B-NP O
had VBD B-VP O
MI NNP B-NP O
age NN I-NP O
59 CD O B-AGE
Review NNP B-NP O
of IN B-PP O
Systems NNP B-NP O
: : O O
Please RB B-ADVP O
see VB B-VP O
pertinent JJ B-NP O
positives NNS I-NP O
and CC I-NP O
negatives NNS I-NP O
in IN B-PP O
HPI. NNP B-NP O
Physical JJ B-NP O
Examination NNP I-NP O
: : O O
Vitals NNS B-NP O
upon IN B-PP O
arriving VBG B-VP O
on IN B-PP O
floor NN B-NP O
: : O O
T NNP B-NP O
96.8 CD I-NP O
BP NNP I-NP O
191/109 CD I-NP O
HR NNP I-NP O
88 CD I-NP O
RR NNP I-NP O
16 CD I-NP O
Sat NNP I-NP O
92 CD I-NP O
% NN I-NP O
on IN B-PP O
2L CD B-NP O
General NNP B-NP O
- : O O
appears VBZ B-VP O
stated VBN I-VP O
age NN B-NP O
, , I-NP O
well-nourished JJ I-NP O
, , I-NP O
increased VBD B-VP O
work NN B-NP O
of IN B-PP O
breathing NN B-NP O
, , O O
NAD NNP B-NP O
HEENT NNP B-NP O
- : O O
NC/AT NN B-NP O
, , O O
PERRL NNP B-NP O
, , O O
moist JJ B-NP O
mucous JJ I-NP O
membranes NNS I-NP O
, , O O
dentures NNS B-NP O
upper JJ B-NP O
palate NN I-NP O
Neck/Nodes NNS B-NP O
- : O O
no DT B-NP O
cervical JJ I-NP O
or CC I-NP O
supraclavicular JJ I-NP O
LAD NN I-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
, , O O
JVP NNP B-NP O
5cm . O O
Pulmonary JJ O O
- : O O
crackles NNS B-NP O
at IN B-PP O
R NN B-NP O
base NN I-NP O
, , O O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
bilaterally . O O
Cardiac NNP B-NP O
- : O O
regular JJ B-NP O
rate NN I-NP O
and CC I-NP O
rhythm NN I-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
physiologic NN B-NP O
splitting NN I-NP O
of IN B-PP O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
Abdomen NNP B-NP O
- : O O
non-distended JJ B-NP O
, , O O
bowel NN B-NP O
sounds VBZ B-VP O
present JJ B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
non-tender JJ I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , O O
no DT B-NP O
HJR NN I-NP O
Skin NNP B-NP O
- : O O
numerous JJ B-NP O
lesions NNS I-NP O
on IN B-PP O
LE NNP B-NP O
's POS B-NP O
in IN B-PP O
various JJ B-NP O
stages NNS I-NP O
of IN B-PP O
healing NN B-NP O
, , O O
fibroma NN B-NP O
on IN B-PP O
upper JJ B-NP O
back NN I-NP O
Extremities NNS B-NP O
- : O O
no DT B-NP O
cyanosis NN I-NP O
or CC I-NP O
clubbing NN I-NP O
, , I-NP O
trace NN I-NP O
edema NN I-NP O
in IN B-PP O
LE NNP B-NP O
's POS B-NP O
bilaterally NN I-NP O
, , O O
1+ JJ B-NP O
pedal NN I-NP O
pulses NNS I-NP O
on IN B-PP O
R, NNP B-NP O
2+ CD I-NP O
pedal NN I-NP O
pulses NNS I-NP O
on IN B-PP O
L NNP B-NP O
Neurology NNP B-NP O
- : O O
alert JJ B-NP O
, , I-NP O
oriented JJ I-NP O
and CC I-NP O
appropriate JJ I-NP O
, , O O
occasionally RB B-NP O
tangential JJ I-NP O
-decreased JJ B-NP O
vibration NN I-NP O
sense NN I-NP O
on IN B-PP O
R NN B-NP O
to TO B-PP O
lower JJR B-NP O
calf NN I-NP O
, , O O
vibration NN B-NP O
sense NN I-NP O
intact JJ I-NP O
on IN B-PP O
L NNP B-NP O
Data NNP B-NP O
: : O O
Chemistry NN B-NP O
Plasma NNP B-NP O
Sodium NNP I-NP O
142 CD I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Potassium NNP I-NP O
4.5 CD I-NP O
( -LRB- I-NP O
3.4-4.8 CD B-PP O
) -RRB- B-NP O
mmol/L . O O
Plasma NNP B-NP O
Chloride NNP I-NP O
114 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
19.1 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
44 CD I-NP O
H NNP B-NP O
(8-25 . O O
) -RRB- O O
mg/dl . O O
Plasma NNP B-NP O
Creatinine NNP I-NP O
2.9 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
0.6-1.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Cardiac NNP B-NP O
Enzymes NNP I-NP O
: : O O
09/06/62 CD B-NP B-DATE
09/06/62 CD I-NP B-DATE
09/06/62 NN I-NP B-DATE
09/06/62 CD O B-DATE
22:13 CD B-NP O
20:26 CD I-NP O
13 CD I-NP O
:51 IN B-PP O
05 CD B-NP O
:50 CD I-NP O
CK NNP B-NP O
357 CD I-NP O
380 CD I-NP O
611( JJ I-NP O
H) NNS I-NP O
CK-MB NNP B-NP O
6.3 CD I-NP O
12.0( CD I-NP O
H) NNP B-NP O
12.0( CD I-NP O
H) . O O
CKMBRI NNP B-NP O
1.8 CD I-NP O
3.2 CD I-NP O
2.0 CD O O
TROP-T NN B-NP O
0.29( CD I-NP O
H) NNP I-NP O
0.21( CD I-NP O
H) NNP B-NP O
0.20( CD I-NP O
H) . O O
Hematology NNP B-NP O
WBC NNP B-NP O
13.3 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
31.4 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
41.0-53.0) CD I-NP O
% NN I-NP O
PLT NNP B-NP O
166 CD I-NP O
( -LRB- I-NP O
150-350 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
87 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
28.9 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
33.4 CD I-NP O
( -LRB- O O
31.0-37.0) CD B-NP O
g/dl NN I-NP O
RDW NNP B-NP O
15.5 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Poly NNP B-NP O
86 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
40-70 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Lymphs NNP B-NP O
8 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
22-44 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Monos NNP B-NP O
5 CD I-NP O
( -LRB- I-NP O
4-11 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
EOS NNS B-NP O
1 CD B-NP O
(0-8 CD I-NP O
) -RRB- O O
% NN O O
Basos NNS B-NP O
0 CD B-NP O
(0-3 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
Absolute JJ B-NP O
Neuts NNP I-NP O
11.42 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
1.8-7.7 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Lymphs NNP I-NP O
1.07 CD I-NP O
( -LRB- I-NP O
1.0-4.8 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Monos NNP I-NP O
0.62 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
0.2-0.4 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
EOS NNP I-NP O
0.19 CD I-NP O
( -LRB- I-NP O
0.1-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Absolute JJ B-NP O
Basos NNP I-NP O
0.04 CD I-NP O
( -LRB- I-NP O
0.0-0.3 CD I-NP O
) -RRB- I-NP O
th/cmm . O O
Urine NN B-NP O
09/06/62 CD B-NP B-DATE
09/06/62 CD I-NP B-DATE
10:20 CD B-NP O
10:17 CD I-NP O
UA-GLUC NNP B-NP O
Negative NNP I-NP O
UA-KET NNP B-NP O
Negative NNP I-NP O
UA-SPGR NNP B-NP O
>1.030 CD I-NP O
UA-BLD NN B-NP O
see VBP B-VP O
detail NN B-NP O
UA-PH NNP B-NP O
5.5 CD I-NP O
UA-ALB NNP B-NP O
3+ CD I-NP O
UA-NIT NNP B-NP O
Negative NNP I-NP O
UA-WBC NNP B-NP O
Negative NNP I-NP O
MIC-SED JJ B-NP O
Completed NNP I-NP O
HCAST NN B-NP O
None NN I-NP O
GCAST NN B-NP O
3-5 CD I-NP O
UAS-RBC NNP B-NP O
3-5 CD I-NP O
UAS-WBC NNP B-NP O
3-5 CD I-NP O
UAS-BACT NNP B-NP O
Negative NNP I-NP O
UAS-SQHI JJ B-NP O
Negative JJ I-NP O
Radiology NN B-NP O
CXR NNP B-NP O
9/06/62 CD I-NP B-DATE
: : O O
IMPRESSION NN B-NP O
: : O O
MILD NNP B-NP O
INCREASE NNP I-NP O
IN IN B-PP O
LINEAR NNP B-NP O
OPACITIES NNP I-NP O
LIKELY NNP I-NP O
SECONDARY NNP I-NP O
TO TO B-PP O
INTERSTITIAL NNP B-NP O
EDEMA. . O O
Cardiogram NN B-NP O
EKG NNP B-NP O
9/06/62 CD I-NP B-DATE
04 CD I-NP O
:41- : O O
87 CD B-NP O
BPM NNP I-NP O
, , I-NP O
NSR NNP I-NP O
, , I-NP O
non-specific JJ I-NP O
T NNP I-NP O
wave NN I-NP O
abnormalities NNS I-NP O
consisting VBG B-VP O
of IN B-PP O
inverted VBN B-NP O
T NNP I-NP O
waves NNS B-NP O
in IN B-PP O
aVL NN B-NP O
(unchanged VBN B-VP O
from IN B-PP O
previous JJ B-NP O
EKG JJ I-NP O
12/30/60 CD I-NP B-DATE
) -RRB- I-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
ischemic JJ B-NP O
changes NNS I-NP O
Assessment/Plan NNP B-NP O
: : O O
In IN B-PP O
summary NN B-NP O
, , O O
Mr. NNP B-NP O
Kaufman NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
53 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
man NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
insulin-requiring JJ B-NP O
DM NNP I-NP O
, , O O
hypertension NN B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
Hepatitis NNP B-NP O
C NNP I-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
acute JJ B-NP O
onset NN I-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
and CC I-NP O
chest NN I-NP O
tightness NN I-NP O
in IN B-PP O
the DT B-NP O
setting NN I-NP O
of IN B-PP O
opioid JJ B-NP O
withdrawal NN I-NP O
. . O O
His PRP$ B-NP O
initial JJ I-NP O
cardiac NN I-NP O
markers NNS I-NP O
were VBD B-VP O
positive JJ B-ADJP O
, , O O
but CC O O
are VBP B-VP O
hard JJ B-ADJP O
to TO B-VP O
interpret VB I-VP O
as IN B-PP O
a DT B-NP O
sign NN I-NP O
of IN B-PP O
ischemia NN B-NP O
in IN B-PP O
the DT B-NP O
setting NN I-NP O
of IN B-PP O
renal JJ B-NP O
failure NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
clinical JJ B-NP O
evidence NN I-NP O
of IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
and CC I-NP O
findings NNS I-NP O
on IN B-PP O
CXR NNP B-NP O
suggestive NN I-NP O
of IN B-PP O
interstitial JJ B-NP O
edema NN I-NP O
. . O O
However RB B-ADVP O
, , O O
his PRP$ B-NP O
JVP NNP I-NP O
was VBD B-VP O
not RB I-VP O
elevated VBN I-VP O
and CC O O
he PRP B-NP O
only RB B-ADVP O
presented VBD B-VP O
with IN B-PP O
mild JJ B-NP O
LE JJ I-NP O
edema NN I-NP O
. . O O
His PRP$ B-NP O
symptoms NNS I-NP O
of IN B-PP O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
left-sided JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
possibly RB B-VP O
caused VBN I-VP O
by IN B-PP O
an DT B-NP O
ischemic JJ I-NP O
event NN I-NP O
. . O O
His PRP$ B-NP O
acute JJ I-NP O
renal JJ I-NP O
failure NN I-NP O
has VBZ B-VP O
multiple JJ B-NP O
possible JJ I-NP O
etiologies NNS I-NP O
( -LRB- O O
some DT B-NP O
of IN B-PP O
which WDT B-NP O
could MD B-VP O
occur VB I-VP O
concurrently RB B-NP O
) -RRB- I-NP O
including VBG I-NP O
CHF NNP I-NP O
, , I-NP O
drug NN I-NP O
toxicity NN I-NP O
( -LRB- B-PP O
lisinopril NN B-NP O
and CC I-NP O
NSAIDs NN I-NP O
) -RRB- I-NP O
, , I-NP O
DM-associated JJ I-NP O
nephropathy NN I-NP O
, , O O
chronic JJ B-NP O
hypertension NN I-NP O
and CC O O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
. . O O
Problem NNP B-NP O
List NNP I-NP O
and CC O O
Plan NNP B-NP O
: : O O
SOB/Chest NNP B-NP O
tightness NN I-NP O
: : O O
--continue JJ B-ADVP O
to TO B-PP O
cycle NN B-NP O
enzymes NNS I-NP O
for IN B-PP O
R/O NN B-NP O
-CXR JJ B-NP O
AP NNP I-NP O
and CC I-NP O
lateral JJ I-NP O
to TO B-VP O
assess VB I-VP O
presence NN B-NP O
of IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
-TTE NN B-NP O
-diuresis NN B-NP O
with IN B-PP O
Lasix NNP B-NP O
20mg CD I-NP O
IV NNP I-NP O
-Hydralazine NN B-NP O
10mg IN B-PP O
QID NNP B-NP O
& CC I-NP O
Isosorbide NNP I-NP O
dinitrate NN I-NP O
5mg IN B-PP O
PO NNP B-NP O
TID NNP I-NP O
-d/c JJ B-NP O
Lisinopril NNP I-NP O
-continue JJ B-NP O
O2 NNP I-NP O
at IN B-PP O
2L NNP B-NP O
, , O O
monitor NN B-NP O
O2 NNS I-NP O
sat VBN O O
-monitor NN B-NP O
ins NNS I-NP O
and CC I-NP O
outs NNS I-NP O
, , O O
daily JJ B-NP O
weights NNS I-NP O
-obtain JJ B-NP O
lipid JJ I-NP O
panel NN I-NP O
to TO B-VP O
assess VB I-VP O
CAD NNP B-NP O
risk NN I-NP O
factors NNS I-NP O
and CC I-NP O
need NN I-NP O
for IN B-PP O
statin NN B-NP O
Renal NNP B-NP O
failure NN I-NP O
: : O O
acute JJ B-ADVP O
over IN B-PP O
chronic NN B-NP O
, , O O
baseline NN B-NP O
nephropathy NN I-NP O
due JJ B-ADJP O
to TO B-PP O
DM NNP B-NP O
and CC I-NP O
HTN NNP I-NP O
, , O O
history NN B-NP O
of IN B-PP O
+protein NN B-NP O
in IN B-PP O
urine NN B-NP O
, , O O
urine JJ B-NP O
sediment NN I-NP O
spun VBD B-VP O
, , O O
no DT B-NP O
signs NNS I-NP O
of IN B-PP O
active JJ B-NP O
sediment NN I-NP O
-urinary JJ B-NP O
electrolytes NNS I-NP O
to TO B-VP O
measure VB I-VP O
FENa . O O
-d/c JJ B-NP O
Lisinopril NNP I-NP O
-dose NN B-NP O
Neurontin NNP I-NP O
according VBG B-VP O
to TO B-PP O
renal JJ B-NP O
function NN I-NP O
-consider NN B-NP O
ruling VBG B-VP O
out RP B-NP O
renal JJ I-NP O
artery NN I-NP O
stenosis NN I-NP O
-obtain JJ B-NP O
urinary JJ I-NP O
eosinophils NNS I-NP O
to TO B-VP O
evaluate VB I-VP O
for IN B-PP O
interstitial JJ B-NP O
nephritis NN I-NP O
Hypertension NNP B-NP O
: : O O
hypertensive JJ B-NP O
emergency NN I-NP O
considered VBN B-VP O
, , O O
but CC O O
determined VBD B-VP O
to TO I-VP O
be VB I-VP O
unlikely JJ B-NP O
due JJ I-NP O
to TO B-LST O
chronity NN B-NP O
of IN B-PP O
elevated JJ B-NP O
SBP NNP I-NP O
at IN B-PP O
similar JJ B-NP O
values NNS I-NP O
, , O O
under IN B-PP O
treatment NN B-NP O
-continue JJ B-NP O
Toprol NNP I-NP O
XL NNP I-NP O
100mg CD I-NP O
QD NNP I-NP O
, , O O
Norvasc NNP B-NP O
5mg CD I-NP O
BID . O O
-add JJ B-NP O
Hydralazine NNP I-NP O
10mg CD I-NP O
QID NNP I-NP O
, , I-NP O
Isosorbide NNP I-NP O
dinitrate NN I-NP O
5mg IN B-PP O
PO NNP B-NP O
TID NNP I-NP O
-monitor NN B-NP O
BP NNP I-NP O
and CC I-NP O
signs NNS I-NP O
and CC I-NP O
symptoms NNS I-NP O
of IN B-PP O
target NN B-NP O
organ NN I-NP O
damage NN I-NP O
closely RB O O
Opioid NNP B-NP O
withdrawal/pain IN B-PP O
management NN B-NP O
: : O O
-Morphine NN B-NP O
PRN NN I-NP O
-consult JJ B-NP O
pain NN I-NP O
service NN I-NP O
DM NNP B-NP O
: : O O
-sliding JJ B-NP O
scale NN I-NP O
insulin NN I-NP O
-obtain JJ B-NP O
Insulin NNP I-NP O
and CC I-NP O
C NNP I-NP O
peptide NN I-NP O
levels NNS I-NP O
because IN B-PP O
unclear JJ B-NP O
if IN B-PP O
currently RB B-VP O
taking VBG I-VP O
Insulin NN B-NP O
Prophylaxis NNP B-NP O
: : O O
-20mg JJ B-NP O
Nexium NNP I-NP O
PO NNP I-NP O
QD . O O
-Heparin NNP B-NP O
5000 CD I-NP O
units NNS I-NP O
SC VBP B-VP O
BID NNP B-NP O
Udo NNP B-NP B-DOCTOR
O. NNP I-NP I-DOCTOR
Zeitler NNP I-NP I-DOCTOR
, , O O
GMS NNP B-NP B-HOSPITAL
III NNP I-NP O
Pager NNP B-NP O
# # I-NP O
61303 CD O B-PHONE
